Proteostasis Therapeutics ROA 2014-2019 | PTI

Current and historical return on assets (ROA) values for Proteostasis Therapeutics (PTI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Proteostasis Therapeutics ROA for the three months ending September 30, 2019 was -55.87%.
Proteostasis Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.06B $0.09B -55.77%
2019-06-30 $-0.07B $0.11B -64.34%
2019-03-31 $-0.06B $0.12B -63.68%
2018-12-31 $-0.06B $0.14B -67.59%
2018-09-30 $-0.06B $0.06B -75.00%
2018-06-30 $-0.05B $0.08B -70.43%
2018-03-31 $-0.06B $0.08B -77.46%
2017-12-31 $-0.06B $0.08B -85.20%
2017-09-30 $-0.06B $0.06B -76.12%
2017-06-30 $-0.05B $0.06B -62.65%
2017-03-31 $-0.04B $0.08B -55.87%
2016-12-31 $-0.04B $0.09B -52.05%
2016-09-30 $-0.04B $0.10B -63.64%
2016-06-30 $-0.03B $0.05B -113.79%
2016-03-31 $-0.02B $0.05B -135.21%
2015-12-31 $-0.02B $0.02B -484.21%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.079B $0.003B
Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $120.026B 13.72
CSL (CSLLY) Australia $93.989B 0.00
Gilead Sciences (GILD) United States $91.816B 11.83
Vertex Pharmaceuticals (VRTX) United States $57.895B 52.54
Biogen (BIIB) United States $53.974B 9.22
Regeneron Pharmaceuticals (REGN) United States $47.485B 20.11
Illumina (ILMN) United States $38.210B 39.50
Alexion Pharmaceuticals (ALXN) United States $20.389B 9.48
Seattle Genetics (SGEN) United States $18.657B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.001B 0.00
Incyte (INCY) United States $16.440B 35.27
BioMarin Pharmaceutical (BMRN) United States $16.134B 690.92
Genmab (GNMSF) Denmark $14.343B 46.13
Galapagos (GLPG) Belgium $13.996B 30.57
Alnylam Pharmaceuticals (ALNY) United States $12.665B 0.00
Exact Sciences (EXAS) United States $11.959B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.059B 51.67
BeiGene (BGNE) Cayman Islands $9.466B 0.00
Moderna (MRNA) United States $8.804B 0.00
Sarepta Therapeutics (SRPT) United States $8.374B 0.00
QIAGEN (QGEN) Netherlands $8.224B 25.33
BioNTech SE (BNTX) Germany $7.666B 0.00
Bio-Techne Corp (TECH) United States $7.402B 50.66
Guardant Health (GH) United States $7.246B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.469B 17.12
Ascendis Pharma (ASND) Denmark $6.207B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.022B 0.00
Reata Pharmaceuticals (RETA) United States $5.712B 0.00
Exelixis (EXEL) United States $5.625B 18.06
ARGENX SE-ADR (ARGX) Netherlands $5.470B 0.00
Amarin (AMRN) Ireland $5.240B 0.00
Acceleron Pharma (XLRN) United States $4.595B 0.00
China Biologic Products (CBPO) China $4.538B 25.56
Repligen (RGEN) United States $4.484B 82.00
Global Blood Therapeutics (GBT) United States $3.720B 0.00
Bluebird Bio (BLUE) United States $3.714B 0.00
Mirati Therapeutics (MRTX) United States $3.670B 0.00
Adaptive Biotechnologies (ADPT) United States $3.577B 0.00
MorphoSys AG (MOR) Germany $3.452B 0.00
Zai Lab (ZLAB) China $3.253B 0.00
Alkermes (ALKS) Ireland $3.097B 245.38
Ultragenyx Pharmaceutical (RARE) United States $3.076B 0.00
Immunomedics (IMMU) United States $3.029B 0.00
Genmab (GMAB) Denmark $3.010B 11.81
CRISPR Therapeutics AG (CRSP) Switzerland $3.008B 50.97
Blueprint Medicines (BPMC) United States $2.938B 0.00
Emergent Biosolutions (EBS) United States $2.877B 19.97
NeoGenomics (NEO) United States $2.872B 125.04
MyoKardia (MYOK) United States $2.842B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.810B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.805B 0.00
Halozyme Therapeutics (HALO) United States $2.802B 0.00
Amicus Therapeutics (FOLD) United States $2.379B 0.00
UniQure (QURE) Netherlands $2.260B 0.00
Arena Pharmaceuticals (ARNA) United States $2.210B 5.77
RA PHARMCTL INC (RARX) United States $2.193B 0.00
Fate Therapeutics (FATE) United States $2.176B 0.00
Insmed (INSM) United States $2.173B 0.00
Principia Biopharma (PRNB) United States $2.068B 0.00
Eidos Therapeutics (EIDX) United States $1.887B 0.00
Epizyme (EPZM) United States $1.864B 0.00
Denali Therapeutics (DNLI) United States $1.827B 0.00
Ligand Pharmaceuticals (LGND) United States $1.815B 53.01
Alector (ALEC) United States $1.785B 0.00
Arvinas (ARVN) United States $1.599B 0.00
Zymeworks (ZYME) Canada $1.564B 0.00
Akcea Therapeutics (AKCA) United States $1.538B 35.61
REGENXBIO (RGNX) United States $1.505B 0.00
Coherus BioSciences (CHRS) United States $1.346B 16.13
Dicerna Pharmaceuticals (DRNA) United States $1.328B 0.00
Revance Therapeutics (RVNC) United States $1.317B 0.00
Myriad Genetics (MYGN) United States $1.288B 22.74
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Zealand Pharma (ZEAL) Denmark $1.255B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.220B 0.00
Editas Medicine (EDIT) United States $1.151B 0.00
Intra-Cellular Therapies (ITCI) United States $1.135B 0.00
Twist Bioscience (TWST) United States $1.073B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.050B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.026B 0.00
Athenex (ATNX) United States $0.972B 0.00
PHARMA MAR SA (PHMMF) Spain $0.932B 0.00
DBV Technologies S.A (DBVT) France $0.912B 0.00
Mesoblast (MESO) Australia $0.859B 0.00
Pharming Group (PHGUF) Netherlands $0.857B 0.00
Cytokineticsorporated (CYTK) United States $0.824B 0.00
Adverum Biotechnologies (ADVM) United States $0.805B 0.00
Codexis (CDXS) United States $0.777B 0.00
Sangamo Therapeutics (SGMO) United States $0.773B 0.00
Heska (HSKA) United States $0.764B 0.00
Vericel (VCEL) United States $0.675B 100.07
Cellectis S.A (CLLS) France $0.672B 0.00
Arcus Biosciences (RCUS) United States $0.661B 0.00
Retrophin (RTRX) United States $0.647B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
Cara Therapeutics (CARA) United States $0.614B 0.00
Intrexon (PGEN) United States $0.605B 0.00
GENFIT S.A (GNFT) France $0.595B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.590B 5.19
Anika Therapeutics (ANIK) United States $0.587B 20.06
ANI Pharmaceuticals (ANIP) United States $0.583B 10.53
Kadmon Holdings (KDMN) United States $0.578B 0.00
Intellia Therapeutics (NTLA) United States $0.568B 0.00
UROGEN PHARMA (URGN) United States $0.559B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.541B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.519B 0.00
Bellus Health (BLU) Canada $0.509B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 11.08
Compugen (CGEN) Israel $0.465B 0.00
NantKwest (NK) United States $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Inovio Pharmaceuticals (INO) United States $0.442B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Mersana Therapeutics (MRSN) United States $0.419B 0.00
Cue Biopharma (CUE) United States $0.410B 0.00
Cel-Sci (CVM) United States $0.399B 0.00
AnaptysBio (ANAB) United States $0.396B 0.00
Merus (MRUS) Netherlands $0.392B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
Precision BioSciences (DTIL) United States $0.389B 0.00
PDL BioPharma (PDLI) United States $0.386B 9.66
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Pfenex (PFNX) United States $0.380B 0.00
Novavax (NVAX) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Clovis Oncology (CLVS) United States $0.375B 0.00
Agenus (AGEN) United States $0.367B 0.00
Sorrento Therapeutics (SRNE) United States $0.366B 0.00
Avid Bioservices (CDMO) United States $0.359B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.358B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.345B 0.00
Dynavax Technologies (DVAX) United States $0.340B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.303B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.294B 2.04
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
Stemline Therapeutics (STML) United States $0.290B 0.00
Albireo Pharma (ALBO) United States $0.288B 0.00
Syros Pharmaceuticals (SYRS) United States $0.282B 0.00
MannKind (MNKD) United States $0.278B 0.00
OSMOTICA PHARM (OSMT) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.269B 0.00
Kamada (KMDA) Israel $0.264B 10.96
Starpharma Holdings (SPHRY) Australia $0.257B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.256B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.247B 0.00
Biofrontera AG (BFRA) Germany $0.246B 0.00
Seres Therapeutics (MCRB) United States $0.239B 0.00
Aduro Biotech (ADRO) United States $0.239B 0.00
VBI Vaccines (VBIV) United States $0.234B 0.00
IVERIC Bio (ISEE) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.216B 0.00
Sutro Biopharma (STRO) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.213B 0.00
XOMA (XOMA) United States $0.208B 0.00
Geron (GERN) United States $0.208B 0.00
Alcobra (ARCT) United States $0.204B 0.00
ChromaDex (CDXC) United States $0.203B 0.00
VTv Therapeutics (VTVT) United States $0.203B 0.00
Prometic Life Sciences (LMNL) Canada $0.201B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.200B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.194B 0.00
Arbutus Biopharma (ABUS) Canada $0.193B 0.00
Athersys (ATHX) United States $0.188B 0.00
Theratechnologies (THTX) Canada $0.181B 0.00
TELA Bio (TELA) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.178B 0.00
Affimed (AFMD) Germany $0.178B 0.00
ADMA Biologics Inc (ADMA) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.173B 0.00
Exicure (XCUR) United States $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Windtree Therapeutics (WINT) United States $0.164B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.160B 8.23
Dyadic (DYAI) United States $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
Selecta Biosciences (SELB) United States $0.153B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.144B 0.00
Verastem (VSTM) United States $0.142B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Aptinyx (APTX) United States $0.137B 0.00
VolitionRX (VNRX) Singapore $0.137B 0.00
Antibe Therapeutics (ATBPF) Canada $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
CorMedix Inc (CRMD) United States $0.133B 0.00
Arsanis (XFOR) United States $0.132B 0.00
Happiness Biotech Group (HAPP) China $0.129B 0.00
ARAVIVE, INC (ARAV) United States $0.128B 0.00
PHASEBIO PHARMA (PHAS) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Celyad SA (CYAD) Belgium $0.125B 0.00
Liquidia Technologies (LQDA) United States $0.117B 0.00
Vaccinex (VCNX) United States $0.107B 0.00
AIT Therapeutics (XAIR) United States $0.107B 0.00
Palatin Technologies (PTN) United States $0.106B 2.89
OvaScience (MLND) United States $0.104B 0.00
Enzo Biochem (ENZ) United States $0.100B 0.00
Prima BioMed (IMMP) Australia $0.096B 0.00
Clearside Biomedical (CLSD) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Adocia (ADOCY) France $0.086B 0.00
Applied Genetic Technologies (AGTC) United States $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.069B 0.00
Pluristem Therapeutics (PSTI) Israel $0.068B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Orgenesis (ORGS) United States $0.067B 4.29
Menlo Therapeutics (MNLO) United States $0.066B 0.00
IBio (IBIO) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.065B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Trevena (TRVN) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
NewLink Genetics (NLNK) United States $0.055B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.044B 0.00
Celldex Therapeutics (CLDX) United States $0.044B 0.00
Curis (CRIS) United States $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Organovo Holdings (ONVO) United States $0.041B 0.00
TOCAGEN INC (TOCA) United States $0.038B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
AmpliPhi Biosciences (ARMP) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.028B 0.00
Pulmatrix (PULM) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
BioCardia (BCDA) United States $0.025B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.024B 0.00
Oncobiologics (OTLK) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Unum Therapeutics (UMRX) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
IMMURON (IMRN) Australia $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.014B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Neuralstem (SNCA) United States $0.003B 0.00